Set up of analytical methods for evaluation of specifications of recombinant Hepatitis-B vaccine

Autor: Daram M, Akbari M, Norouzi M, Ajdary S, Mahmoudi M, Pakzad SR, Karimzadeh H, Jazayeri SM

Publikováno v: Tehran University Medical Journal, Vol 67, Iss 3, Pp 159-167 (2009)

"nBackground: Hepatitis B vaccination has been included in routine immunization of all individuals according to WHO recommendations since 1991. Despite successful coverage, 3-5% of recipients fail to mount a desirable protection level of Ab. Vaccine

Externí odkaz: https://doaj.org/article/bd07e907dbea405f956a460464e82235

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fabrication of chitosan-polyethylene glycol nanocomposite films containing ZIF-8 nanoparticles for application as wound dressing materials.

Autor: Mazloom-Jalali A; Department of Chemistry, Amirkabir University of Technology (Tehran Polytechnic), P.O.Box: 15875-4413, Tehran, Iran., Shariatinia Z; Department of Chemistry, Amirkabir University of Technology (Tehran Polytechnic), P.O.Box: 15875-4413, Tehran, Iran. Electronic address: shariati@aut.ac.ir., Tamai IA; Department of Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran., Pakzad SR; Food and Drug Control Laboratories, Food and Drug Deputy, Iran Ministry of Health and Medical Education, Tehran, Iran., Malakootikhah J; Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, Iran.

Publikováno v: International journal of biological macromolecules [Int J Biol Macromol] 2020 Jun 15; Vol. 153, pp. 421-432. Date of Electronic Publication: 2020 Mar 06.

Review of the current use and evaluation of cell substrates for producing biologicals in selected countries.

Autor: Kang HN; World Health Organization, Department of Essential Medicines and Health Products, Avenue Appia 20, CH-1211 Geneva, Switzerland. Electronic address: kangh@who.int., Xu M; Institute for Biological Product Control, National Institutes for Food and Drug Control, People's Republic of China., Rodríguez VP; Centro para el Control Estatal de la Calidad de los Medicamentos, Cuba., Mefed K; Scientific Center for Expertise of Pharmaceuticals for Medical Use, Ministry of Public Health, Russia., Hanada K; Department of Biochemistry & Cell Biology, National Institute of Infectious Diseases, Japan., Ahn KS; National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Korea., Gangakhedkar SJ; Central Drugs Standard Control Organization, India., Pakzad SR; Vaccine Potency Section, Food and Drug Control Laboratories & Research Center, Islamic Republic of Iran., Prawahju EI; National Quality Control Laboratory of Drug and Food, National Agency of Drug and Food Control, Indonesia., Lee N; National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Korea., Phumiamorn S; Institute of Biological Products, Ministry of Public Health, Thailand., Nemec M; Biologics and Genetic Therapies Directorate, Health Canada, Canada., Meng S; Institute for Biological Product Control, National Institutes for Food and Drug Control, People's Republic of China., Knezevic I; World Health Organization, Department of Essential Medicines and Health Products, Avenue Appia 20, CH-1211 Geneva, Switzerland.

Publikováno v: Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2015 May; Vol. 43 (3), pp. 153-7. Date of Electronic Publication: 2015 Feb 21.

IgG1 and IgG2a profile of serum antibodies to Leishmania major amastigote in BALB/c and C57BL/6Mice.

Autor: Ebrahimpoor S; Immunology Department, Pasteur Institute of Iran, Pasteur Ave., Tehran, Iran. sedighe.ebrahimpoor@yahoo.com., Pakzad SR, Ajdary S

Publikováno v: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2013 Aug 28; Vol. 12 (4), pp. 361-7. Date of Electronic Publication: 2013 Aug 28.